January 3, 2025 Registration Statement Nos. 333-270004 and 333-270004-01; Rule 424(b)(3)
Amendment no. 1 to pricing supplement dated December 27, 2024 to product supplement no. 4-I dated April 13, 2023, underlying supplement no. 1-I dated
April 13, 2023, the prospectus and prospectus supplement, each dated April 13, 2023, and the prospectus addendum dated June 3, 2024
JPMorgan Chase Financial Company LLC
Structured Investments
Capped Dual Directional Buffered Return Enhanced
Notes Linked to the S&P 500® Futures Excess Return
Index due July 1, 2027
Fully and Unconditionally Guaranteed by JPMorgan Chase & Co.
Notwithstanding anything to the contrary set forth in the pricing supplement dated December 27, 2024, related to the notes referred to
above (the “pricing supplement”), the Fees and Commissions and the Proceeds to Issuer are as set forth below:
Price to Public (1)
Fees and Commissions (2)
Proceeds to Issuer
Per note
$1,000
$27.50
$972.50
Total
$1,070,000
$29,425
$1,040,575
(1) See “Supplemental Use of Proceeds” in the pricing supplement for information about the components of the price to public of the notes.
(2) J.P. Morgan Securities LLC, which we refer to as JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions
of $27.50 per $1,000 principal amount note it receives from us to other affiliated or unaffiliated dealers. See “Plan of Distribution (Conflicts
of Interest)” in the accompanying product supplement.
CUSIP: 48135WVQ6
Investing in the notes involves a number of risks. See “Risk Factors” beginning on page S-2 of the accompanying
prospectus supplement, Annex A to the accompanying prospectus addendum, Risk Factors” beginning on page PS-11 of the
accompanying product supplement and “Selected Risk Considerations” beginning on page PS-5 of the pricing supplement.
Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of the
notes or passed upon the accuracy or the adequacy of this amendment, the pricing supplement or the accompanying product
supplement, underlying supplement, prospectus supplement, prospectus and prospectus addendum. Any representation to the
contrary is a criminal offense.
The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and
are not obligations of, or guaranteed by, a bank.
You should read this amendment together with the pricing supplement and the related product supplement, underlying supplement,
prospectus supplement and prospectus and prospectus addendum, each of which can be accessed via the hyperlinks below. Please
also see “Additional Terms Specific to the Notes” in the pricing supplement.
Pricing supplement dated December 27, 2024:
Product supplement no. 4-I dated April 13, 2023:
Underlying supplement no. 1-I dated April 13, 2023:
Prospectus supplement and prospectus, each dated April 13, 2023:
Prospectus addendum dated June 3, 2024:

Alerian Mlp Index ETNs d... (AMEX:AMJB)
過去 株価チャート
から 12 2024 まで 1 2025 Alerian Mlp Index ETNs d...のチャートをもっと見るにはこちらをクリック
Alerian Mlp Index ETNs d... (AMEX:AMJB)
過去 株価チャート
から 1 2024 まで 1 2025 Alerian Mlp Index ETNs d...のチャートをもっと見るにはこちらをクリック